Endothelial Dysfunction as a Predictive Marker of Acute Graft-Versus-Host Disease in Adult Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort)

NCT02344953 ·Status: UNKNOWN

Multi-omic Characterization of Pediatric and Adult Patients Undergoing Hematopoietic Stem Cell Transplantation and Advanced Cell Therapies

NCT07464483 ·Status: RECRUITING ·Phase: NA

Donor Neutrophil Subsets to Predict the Risk of aGVHD

NCT06394895 ·Status: ACTIVE_NOT_RECRUITING

Study on the Serum Metabolic Markers and Early Complications After Allo-HSCT： Cohort Study

NCT06386445 ·Status: NOT_YET_RECRUITING

Impact of Pulmonary Follow-up After Stem Cell Graft

NCT03349372 ·Status: COMPLETED

Improving Outcomes Assessment in Chronic GVHD

NCT00637689 ·Status: ACTIVE_NOT_RECRUITING

Symptom Experience and Self-management After Haematopoietic Stem Cell Transplantation

NCT01275534 ·Status: COMPLETED

Prevention of GVHD in Patients Treated With Allogeneic SCT: Possible Role of Extracorporeal Photophoresis

NCT03204721 ·Status: COMPLETED ·Phase: NA

Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic Diseases

NCT06294691 ·Status: RECRUITING ·Phase: PHASE3

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

NCT04098445 ·Status: RECRUITING

Prophylaxis of Graft-versus-host Disease With Anti-CD25 Antibody in Patients Underwent HSCT

NCT06334367 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Pulmonary Complications of Allografts

NCT01219972 ·Status: COMPLETED

Inflammatory Response to Paramyxovirus Infection in an Ex-vivo Model of Bronchial Epithelial Cells in Allogeneic HSCT Recipients

NCT03684083 ·Status: UNKNOWN

Assessing the Incidence of Transplant Associated Thrombotic Microangiopathy (TA-TMA) in Adult Patients Undergoing Allogeneic Stem Cell Transplant (SCT)

NCT07381205 ·Status: NOT_YET_RECRUITING

Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation

NCT07349498 ·Status: RECRUITING

Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant

NCT00898612 ·Status: WITHDRAWN

Allogeneic Hematopoietic Stem Cell Transplantation Evaluation in High Risk Myelodysplasia: an Observational Non-interventional Study

NCT01095874 ·Status: COMPLETED

Longitudinal Pulmonary Chronic Graft-versus-host-disease (GvHD) Assessment in Hematopoietic Stem Cell Transplantation (HSCT) Patients

NCT07297303 ·Status: RECRUITING

Immune Monitoring After Allogeneic Hematopoietic Stem Cell Transplantation

NCT03233659 ·Status: COMPLETED

Prospective Cohort for the Evaluation of Biomarkers Following HCT (BMT CTN 1202)

NCT01879072 ·Status: COMPLETED

Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies

NCT06294678 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

Study of Non-Myeloablative Haplo-identical Haematopoietic Stem Cell Transplantation in Patients With Haematological Malignancies or Acquired Aplastic Anaemia

NCT01719341 ·Status: UNKNOWN

Growth and Endocrinological Outcomes in Patients Who Underwent or Did Not Undergo Haematopoietic Stem Cell Transplantation in Prepubertal Age

NCT07490392 ·Status: NOT_YET_RECRUITING

The Skin Microbiome in Graft Versus Host Disease

NCT04231500 ·Status: ACTIVE_NOT_RECRUITING

Kinetic Analysis of Immune Cells in Blood and Chronic Graft-Versus-Host Disease-Affected Tissues After Allogeneic Hematopoietic Cell Transplantation

NCT07235501 ·Status: NOT_YET_RECRUITING